These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8422095)

  • 1. Relapse in a clozapine responder following lorazepam withdrawal.
    Kanofsky JF; Lindenmayer JP
    Am J Psychiatry; 1993 Feb; 150(2):348-9. PubMed ID: 8422095
    [No Abstract]   [Full Text] [Related]  

  • 2. Immediate recurrence of psychotic symptoms after discontinuation of clozapine: a case report.
    Tanríverdi N; Yazící KM
    Biol Psychiatry; 1996 May; 39(9):814-5. PubMed ID: 8731523
    [No Abstract]   [Full Text] [Related]  

  • 3. Seizures after discontinuation of low-dose lorazepam from originally seizure-free clozapine regimen: combined effects?
    Lane HY; Su KP; Chang WH
    J Clin Psychiatry; 1999 Jun; 60(6):408-9. PubMed ID: 10401922
    [No Abstract]   [Full Text] [Related]  

  • 4. Withdrawal dyskinesia after abrupt cessation of clozapine and benztropine.
    Songer DA; Schulte HM
    J Clin Psychiatry; 1996 Jan; 57(1):40. PubMed ID: 8543548
    [No Abstract]   [Full Text] [Related]  

  • 5. Sudden death after intravenous application of lorazepam in a patient treated with clozapine.
    Klimke A; Klieser E
    Am J Psychiatry; 1994 May; 151(5):780. PubMed ID: 8166326
    [No Abstract]   [Full Text] [Related]  

  • 6. Neuroleptic malignant syndrome related to a switch to perospirone and anticholinergic withdrawal.
    Tanii H; Fujita K; Okazaki Y
    Am J Psychiatry; 2006 Mar; 163(3):547-8. PubMed ID: 16513884
    [No Abstract]   [Full Text] [Related]  

  • 7. [Description of a patient with schizophrenia and coexisting megadose lorazepam dependence with slightly expressed withdrawl symptoms during drug reduction. A case report].
    Schylla A; Scisło P; Badura-Brzoza K; Pasierb N
    Wiad Lek; 2012; 65(4):243-6. PubMed ID: 23654146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ECT following clozapine.
    Masiar SJ; Johns CA
    Br J Psychiatry; 1991 Jan; 158():135-6. PubMed ID: 2015444
    [No Abstract]   [Full Text] [Related]  

  • 9. Lithium-responsive schizophrenia: case reports.
    Prakash R
    J Clin Psychiatry; 1985 Apr; 46(4):141-2. PubMed ID: 3980453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myoclonus during treatment with clozapine and lithium: the role of serotonin.
    Lemus CZ; Lieberman JA; Johns CA
    Hillside J Clin Psychiatry; 1989; 11(2):127-30. PubMed ID: 2488054
    [No Abstract]   [Full Text] [Related]  

  • 11. [Extrapyramidal symptoms following Clozapine therapy. Case report].
    Doepp S; Buddeberg C
    Nervenarzt; 1975 Oct; 46(10):589-90. PubMed ID: 811999
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of fluoxetine on serum clozapine levels.
    Kingsbury SJ; Puckett KM
    Am J Psychiatry; 1995 Mar; 152(3):473-4. PubMed ID: 7864284
    [No Abstract]   [Full Text] [Related]  

  • 13. Reduction of side effects by combining clozapine with amisulpride: case report and short review of clozapine-induced hypersalivation-a case report.
    Croissant B; Hermann D; Olbrich R
    Pharmacopsychiatry; 2005 Jan; 38(1):38-9. PubMed ID: 15706466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Digestive symptoms in the course of benzodiazepine withdrawal syndrome].
    Louvel D; Delvaux M; Larrue V; Moreau J; Bonnafous C; Bueno L; Frexinos J
    Gastroenterol Clin Biol; 1994; 18(11):1038-9. PubMed ID: 7705565
    [No Abstract]   [Full Text] [Related]  

  • 15. Mania induced by lorazepam withdrawal: a report of two cases.
    Turkington D; Gill P
    J Affect Disord; 1989; 17(1):93-5. PubMed ID: 2525581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disinhibition after lorazepam augmentation of antipsychotic medication.
    Little JD; Taghavi EH
    Am J Psychiatry; 1991 Aug; 148(8):1099-100. PubMed ID: 1677237
    [No Abstract]   [Full Text] [Related]  

  • 17. A case report of lorazepam withdrawal.
    Stewart RB; Salem RB; Springer PK
    Am J Psychiatry; 1980 Sep; 137(9):1113-4. PubMed ID: 6107050
    [No Abstract]   [Full Text] [Related]  

  • 18. Fluvoxamine augmentation for clozapine-resistant schizophrenia.
    Silver H; Kaplan A; Jahjah N
    Am J Psychiatry; 1995 Jul; 152(7):1098. PubMed ID: 7793452
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention of clozapine-induced granulocytopenia/agranulocytosis with granulocyte-colony stimulating factor (G-CSF) in an intellectually disabled patient with schizophrenia.
    Rajagopal G; Graham JG; Haut FF
    J Intellect Disabil Res; 2007 Jan; 51(Pt 1):82-5. PubMed ID: 17181606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of 6 different methods for lorazepam withdrawal. A controlled study, hydroxyzine versus placebo].
    Lemoine P; Touchon J; Billardon M
    Encephale; 1997; 23(4):290-9. PubMed ID: 9417395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.